Resultado da Busca
23 de abr. de 2024 · Most people who get dengue will not have symptoms. But for those who do, the most common symptoms are high fever, headache, body aches, nausea, and rash. Most will get better in 1–2 weeks. Some people develop severe dengue and need care in a hospital. In severe cases, dengue can be fatal.
A OPAS/OMS fornece assessoria e apoio técnico para prevenir e controlar a dengue. Este trabalho é realizado com base na Estratégia de Gestão Integrada para a Prevenção e Controle das Arboviroses, adotada pelos Estados Membros da OPAS/OMS em 2016 (CD55.R6). Em 2008, os Estados Membros da OPAS/OMS estabeleceram uma Rede de Laboratórios de ...
30 de mai. de 2024 · As of 30 April 2024, over 7.6 million dengue cases have been reported to WHO in 2024, including 3.4 million confirmed cases, over 16 000 severe cases, and over 3000 deaths. While a substantial increase in dengue cases has been reported globally in the last five years, this increase has been particularly pronounced in the Region of the Americas, where the number of cases has already exceeded ...
3 de out. de 2024 · Dengue and severe dengue. Dengue is a mosquito-borne viral infection that is common in warm, tropical climates. Infection is caused by any one of four closely related dengue viruses (called serotypes) and these can lead to a wide spectrum of symptoms, including some which are extremely mild (unnoticeable) to those that may require medical ...
Dengue is transmitted by the bite of an infected mosquito. It is an illness that affects infants, young children, and adults, with symptoms ranging from mild fever to incapacitating high fever, with severe headache, pain behind the eyes, muscle and joint pain, and rash. The illness can evolve to severe dengue, characterized by shock ...
2 de out. de 2024 · Dengue is a mosquito-borne viral infection that causes a severe flu-like illness and sometimes a potentially lethal complication called severe dengue. The incidence of dengue has increased 30-fold over the last 50 years. Up to 50–100 million infections are now estimated to occur annually in over 100 endemic countries, putting almost 4 billion people at risk.
21 de abr. de 2009 · Since the second edition of Dengue haemorrhagic fever: diagnosis, treatment, prevention and control was published by the World Health Organization (WHO) in 1997, the magnitude of the dengue problem has increased dramatically and has extended geographically to many previously unaffected areas. It was then, and remains today, the most important ...
7 de out. de 2024 · Na Região das Américas, o número de casos de dengue registrados durante o primeiro semestre de 2024 excedeu o número de casos historicamente notificados em um ano, em comparação com todos os anos registrados anteriormente. Até a semana epidemiológica 36 de 2024, 47 países e territórios na Região das Américas notificaram 11.732.921 casos de dengue; esse número é duas vezes e meio ...
21 de dez. de 2023 · The global incidence of dengue has markedly increased over the past two decades, posing a substantial public health challenge. From 2000 to 2019, the World Health Organization (WHO) documented a ten-fold surge in reported cases worldwide increasing from 500 000 to 5.2 million. The year 2019 marked an unprecedented peak, with reported instances ...
10 de mai. de 2024 · TAK-003 is a live-attenuated vaccine containing weakened versions of dengue virus serotypes 1, 2, 3 and 4 developed by Takeda. TAK-003 uses the DENV2 strain as the genomic backbone. The vaccine schedule is a 2-dose series three months apart, given to specific age groups and in specific circumstances according to WHO recommendations.
